Viewing data from:

PHENELZINE SULFATE

ANDA

PHENELZINE SULFATE | A200181 | NOVEL LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: NARDIL(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Phenelzine Sulfate (2023)

Total Spending

$1.1M

Total Claims

11,564

Beneficiaries

2,029

Avg Cost/Unit

$0.58

Spending Trend

$1.4M(2019)→$1.2M(2020)→$1.2M(2021)→$1.1M(2022)→$1.1M(2023)

YoY Change:-0.5%

5yr CAGR:-0.6%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

PROCOS SPAPHENELZINE SULFATE

DMF 43281981

SIEGFRIED EVIONNAZ SAPHENELZINE SULFATE

DMF 77901988

TYCHE INDUSTRIES LTDPHENELZINE SULFATE

DMF 313032017

CML EUROPE BVInactivePHENELZINE SULFATE

DMF 184002005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 15MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 8, 2010

No patent or exclusivity listings for this strength.